Delivery Order SPE2DB20D9331-SPE2DB24FL0P2
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a firm fixed-price delivery order ceiling value of $4,541.76 and covers the supply of Telmisartan 20 mg tablets to fulfill the recurring pharmaceutical needs of military health facilities. DMS Pharmaceutical Group holds a larger indefinite-delivery contract (IDC) with the DLA under the...
- This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,828 contract was issued by the Defense Logistics Agency (DLA) under the SPE2DB program, a $499,999,999 indefinite delivery contract that enables DLA to place orders for a wide range of pharmaceutical products to support the medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. The delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,671.69 firm fixed-price delivery order is for the provision of Telmisartan 40 mg tablets to support the recurring pharmaceutical supply needs of U.S. military healthcare facilities. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,678.00 to DMS Pharmaceutical Group Inc. on September 17, 2025, for the supply of Telmisartan 40 mg tablets (30-count units). This firm fixed-price delivery order, which must be completed by September 18, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge location. The...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) under its SPE2DB program. The award has a ceiling value of $9,210.24 and covers the delivery of 4554944974 - Telmisartan 40 mg Tablets 30s to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the supply of 4565634300 - Telmisartan 20 mg Tablet 30s, a pharmaceutical product. The contract has a ceiling value of $2,148.29 and an ultimate completion date of August 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,363.27, is for the delivery of Telmisartan 80 mg tablets to support military healthcare programs. The contract is a firm fixed-price delivery order, with an ultimate completion date of January 9, 2024. This order is part of a larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,656.68 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count packaging). This contract was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and utilizes firm fixed pricing with no set-aside designation. The awardee, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a competitive...
- The U.S. government, through the Defense Logistics Agency (DLA), awarded a $12,407.04 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Telmisartan 40 mg tablets, a cardiovascular medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with the DLA Troop Support Medical. The IDC serves as the primary...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan 20 mg tablets, with a firm fixed price of $11,137.31 and a completion date of May 30, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB24FL0P2Delivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,892.40, is for the delivery of Telmisartan 20 mg tablets over a term ending on February 2, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999 and running through December 31, 2025. Through this IDC, DMS Pharmaceutical Group provides a wide range of pharmaceutical products, from common medications to specialized drugs and medical supplies, to support the recurring medical needs of military healthcare facilities worldwide. The company's role as a prime vendor for the DLA's pharmaceutical supply chain is a critical component in ensuring the availability of essential medications for the U.S. Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 2/1/24 |